Search research articles
Contact Us
Filters
Showing results (51-60 of 116) with videos related to
Page
of 12
Sort By:
Annals of the New York Academy of Sciences
|
July 23, 2005
Advanced glycation end products/peptides: an in vivo investigation
A Lapolla, D Fedele, R Reitano, et al.
Biochimica Et Biophysica Acta
|
November 25, 1993
A study on in vitro glycation processes by matrix-assisted laser desorption ionization mass spectrometry
A Lapolla, C Gerhardinger, L Baldo, et al.
Diabetes & Metabolism
|
February 20, 2002
Antepartum and early postpartum predictors of type 2 diabetes development in women with gestational diabetes mellitus
M G Dalfrà, A Lapolla, M Masin, et al.
Journal of Diabetes and Its Complications
|
April 29, 1998
Pregnancy does not induce or worsen retinal and peripheral nerve dysfunction in insulin-dependent diabetic women
A Lapolla, C Cardone, P Negrin, et al.
Diabetes
|
June 1, 1988
Reduced in vivo biological activity of in vitro glycosylated insulin
A Lapolla, P Tessari, T Poli, et al.
Journal of Mass Spectrometry : JMS
|
May 3, 2001
Advanced glycation end products: a highly complex set of biologically relevant compounds detected by mass spectrometry
A Lapolla, D Fedele, L Martano, et al.
The American Journal of Dermatopathology
|
May 2, 2025
Concomitant Squamous Cell Carcinoma and Mycosis Fungoides Within the Same Lesion: A Case Report and Literature Review
Apoorva Mehta, Anna Bowling, Emily R Gordon, et al.
Diabetes
|
January 1, 1990
Absence of brown product FFI in nondiabetic and diabetic rat collagen
A Lapolla, C Gerhardinger, B Pelli, et al.
Rapid Communications in Mass Spectrometry : RCM
|
January 28, 1999
Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry
A Lapolla, D Fedele, M Plebani, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 20, 2019
Clinical benefits of switching to insulin degludec irrespective of previous basal insulin therapy in people with Type 1 or Type 2 diabetes: evidence from a European, multicentre, retrospective, non-interventional study (EU-TREAT)
S T Knudsen, A Lapolla, B Schultes, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 116) with videos related to
Sort By:
Page
of 12
Annals of the New York Academy of Sciences
|
July 23, 2005
Advanced glycation end products/peptides: an in vivo investigation
A Lapolla, D Fedele, R Reitano, et al.
Biochimica Et Biophysica Acta
|
November 25, 1993
A study on in vitro glycation processes by matrix-assisted laser desorption ionization mass spectrometry
A Lapolla, C Gerhardinger, L Baldo, et al.
Diabetes & Metabolism
|
February 20, 2002
Antepartum and early postpartum predictors of type 2 diabetes development in women with gestational diabetes mellitus
M G Dalfrà, A Lapolla, M Masin, et al.
Journal of Diabetes and Its Complications
|
April 29, 1998
Pregnancy does not induce or worsen retinal and peripheral nerve dysfunction in insulin-dependent diabetic women
A Lapolla, C Cardone, P Negrin, et al.
Diabetes
|
June 1, 1988
Reduced in vivo biological activity of in vitro glycosylated insulin
A Lapolla, P Tessari, T Poli, et al.
Journal of Mass Spectrometry : JMS
|
May 3, 2001
Advanced glycation end products: a highly complex set of biologically relevant compounds detected by mass spectrometry
A Lapolla, D Fedele, L Martano, et al.
The American Journal of Dermatopathology
|
May 2, 2025
Concomitant Squamous Cell Carcinoma and Mycosis Fungoides Within the Same Lesion: A Case Report and Literature Review
Apoorva Mehta, Anna Bowling, Emily R Gordon, et al.
Diabetes
|
January 1, 1990
Absence of brown product FFI in nondiabetic and diabetic rat collagen
A Lapolla, C Gerhardinger, B Pelli, et al.
Rapid Communications in Mass Spectrometry : RCM
|
January 28, 1999
Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry
A Lapolla, D Fedele, M Plebani, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 20, 2019
Clinical benefits of switching to insulin degludec irrespective of previous basal insulin therapy in people with Type 1 or Type 2 diabetes: evidence from a European, multicentre, retrospective, non-interventional study (EU-TREAT)
S T Knudsen, A Lapolla, B Schultes, et al.
Page
of 12